Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia (Q36223356)

12 August 2017

Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemia (English)

1 reference

12 August 2017

1 reference

4

Takaomi Sanda

1 reference

12 August 2017

20

A Thomas Look

1 reference

12 August 2017

Alex Kentsis

1

1 reference

12 August 2017

Casie Reed

2

1 reference

12 August 2017

Kim L Rice

3

1 reference

12 August 2017

Scott J Rodig

5

1 reference

12 August 2017

Eleni Tholouli

6

1 reference

12 August 2017

Amanda Christie

7

1 reference

12 August 2017

Peter J M Valk

8

1 reference

12 August 2017

Ruud Delwel

9

1 reference

12 August 2017

Vu Ngo

10

1 reference

12 August 2017

Jeffery L Kutok

11

1 reference

12 August 2017

Suzanne E Dahlberg

12

1 reference

12 August 2017

Lisa A Moreau

13

1 reference

12 August 2017

Richard J Byers

14

1 reference

12 August 2017

James G Christensen

15

1 reference

12 August 2017

George Vande Woude

16

1 reference

12 August 2017

Jonathan D Licht

17

1 reference

12 August 2017

Andrew L Kung

18

1 reference

12 August 2017

Louis M Staudt

19

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 July 2012

1 reference

12 August 2017

1 reference

12 August 2017

18

1 reference

12 August 2017

7

1 reference

12 August 2017

1118-1122

1 reference

FLT3 ligand impedes the efficacy of FLT3 inhibitors in vitro and in vivo

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Therapeutic advances in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Dysregulated gene expression networks in human acute myelogenous leukemia stem cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Enhanced activation of STAT pathways and overexpression of survivin confer resistance to FLT3 inhibitors and could be therapeutic targets in AML.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

High-throughput sequence analysis of the tyrosine kinome in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Synthetic lethal screen identification of chemosensitizer loci in cancer cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Phosphotyrosine profiling identifies the KG-1 cell line as a model for the study of FGFR1 fusions in acute myeloid leukemia

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

shRNA libraries and their use in cancer genetics

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Dissecting cancer pathways and vulnerabilities with RNAi

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

A loss-of-function RNA interference screen for molecular targets in cancer

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Met, metastasis, motility and more

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Lack of KIT or FMS internal tandem duplications but co-expression with ligands in AML.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

The protein tyrosine kinase family of the human genome

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain.

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Expression of a retinoic acid receptor gene in myeloid leukemia cells

1 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Prognostically useful gene-expression profiles in acute myeloid leukemia.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Autocrine secretion and malignant transformation of cells.

22 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

Accurate detection of uniparental disomy and microdeletions by SNP array analysis in myelodysplastic syndromes with normal cytogenetics

22 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM.2819

Detection of MYCN gene amplification in neuroblastoma by fluorescence in situ hybridization: a pediatric oncology group study.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM.2819

Inhibition of FLT3 in MLL. Validation of a therapeutic target identified by gene expression based classification

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM.2819

Constitutive p38HOG mitogen-activated protein kinase activation induces permanent cell cycle arrest and senescence

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3438345

5 December 2018

Identifiers

DOI

10.1038/NM.2819

1 reference

Dimensions Publication ID

12 August 2017

0 references

1 reference

12 August 2017

PubMed publication ID

22683780

1 reference